Abstract
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and a leading cause of sudden cardiac death in young individuals and athletes. Historically, exercise restrictions were advised because of concerns about arrhythmias, left ventricular outflow tract (LVOT) obstruction, and adverse remodeling; however, emerging evidence challenges these recommendations.
To systematically evaluate the effects of structured and habitual exercise on cardiac structure, function, biomarkers, functional capacity, and safety in individuals with HCM.
We performed a systematic review and meta-analysis in accordance with PRISMA 2020 guidelines. Randomized and observational studies including patients ≥12 years with confirmed HCM participating in structured exercise or habitual physical activity were eligible. Comparators included usual care, lower-intensity exercise, or sedentary controls. Outcomes included cardiac remodeling parameters (wall thickness, chamber volumes, LVOT gradient, diastolic function), left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP), peak oxygen consumption (VO₂ peak), body mass index (BMI), and major adverse clinical events. Random-effects models were used for pooled analyses.
Eleven studies (1,457 participants) were included. Exercise was not associated with adverse changes in wall thickness, chamber volumes, LVEF, LVOT gradient, diastolic indices, BNP, or BMI. VO₂ peak changes were heterogeneous, with some trials demonstrating individualized functional improvement. No study reported excess adverse events, including sudden cardiac death, ventricular arrhythmias, syncope, or appropriate ICD therapy.
Structured and habitual exercise appear safe in HCM, without evidence of adverse remodeling or increased arrhythmic risk. Functional benefits vary, supporting individualized, supervised exercise prescriptions and more patient-centered counseling.